mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.5 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |